首页 | 本学科首页   官方微博 | 高级检索  
     


S100A9 a new marker for monocytic human myeloid-derived suppressor cells
Authors:Zhao Fei  Hoechst Bastian  Duffy Austin  Gamrekelashvili Jaba  Fioravanti Suzanne  Manns Michael P  Greten Tim F  Korangy Firouzeh
Affiliation:National Institutes of Health, National Cancer Institute, Medical Oncology Branch, Bethesda, MD 20892, USA.
Abstract:
Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of cells that negatively regulate the immune response during tumour progression, inflammation and infection. Only limited data are available on human MDSC because of the lack of specific markers. We have identified members of the S100 protein family-S100A8, S100A9 and S100A12 - specifically expressed in CD14(+) HLA-DR(-/low) MDSC. S100A9 staining in combination with anti-CD14 could be used to identify MDSC in whole blood from patients with colon cancer. An increase in the population of CD14(+) S100A9(high) MDSC was observed in the peripheral blood from colon cancer patients in comparison with healthy controls. Finally, nitric oxide synthase expression, a hallmark of MDSC, was induced in CD14(+) S100A9(high) upon lipopolysaccharide/interferon-γ stimulation. We propose S100 proteins as useful markers for the analysis and further characterization of human MDSC.
Keywords:cancer  flow cytometry/FACS  immune response  tolerance  tumour immunology
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号